Ingredion
INGR
94.25
-2.50
-2.58%
Ingredion
US · INGR
#1925 by market cap
Listed 1970
94.25
-2.50
-2.58%
Live - 5344 symbols - heartbeat 513s ago
· 2026-10-07 19:54
After-hours
94.25
0.00%
- Market cap
- 5.94B
- P/E (TTM)i
- 10.24
- P/Bi
- 1.31
- EPSi
- 11.18
- Div yieldi
- 3.48%
- 52W posi
- 5%
Reader sentiment
Are you bullish or bearish on INGR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 1 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.2 percentage points.
Institutional ownership
- Held by institutions
- 99.49% +0.18pp
- Institutions
- 699 -1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund81.17%
Hedge Fund8.11%
Public Company4.43%
Government Pension Fund2.32%
Private Company1.28%
Sovereign Wealth Fund1.07%
Individual/Insider0.50%
Insurance Company0.36%
Family Office/Trust0.29%
Other0.48%
Top holders as of 2026-06-30
BlackRock
10.36% · 6.53M sh
Vanguard Portfolio Management, LLC
7.74% · 4.88M sh
Dimensional Fund Advisors
5.32% · 3.36M sh
Vanguard Capital Management, LLC
5.13% · 3.24M sh
LSV Asset Management
3.59% · 2.27M sh
State Street Global Advisors
3.54% · 2.23M sh
FMR
2.42% · 1.53M sh
AQR Capital Management
2.38% · 1.50M sh
Yacktman Asset Management LP
2.33% · 1.47M sh
First Trust Advisors L.P.
2.19% · 1.38M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 41 buys · 5 sells
| Name | Role | Stake |
|---|---|---|
| James Zallie | Chief Executive Officer | 0.12% |
| James Gray | Chief Financial Officer | 0.09% |
| Robert Ritchie | Senior VP of Food & Industrial Ingredients of America | 0.05% |
| Larry Fernandes | Senior VP and Chief Commercial & Sustainability Officer | 0.04% |
| Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | 0.04% |
| Jorge Alberto Uribe Lopez | Independent Director | 0.03% |
| Valdirene Evans | Senior VP, President of APAC and Global Head of Pharma, Home & Beauty | 0.02% |
| Nancy Wolfe | Chief Human Resources Officer | 0.02% |
| Tanya M. de Foras | Senior VP, Chief Legal Officer, Corporate Secretary & Chief Compliance Officer | 0.02% |
| Michael O'Riordan | SVP of T&HS EMEA & Asia-Pacific | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-29 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +18 | -- |
| 2026-09-29 | Charles Magro | Independent Director | Other Derivative Acquisition | +266 | -- |
| 2026-09-14 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | -- |
| 2026-09-14 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +28 | -- |
| 2026-08-30 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +16 | -- |
| 2026-08-30 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +33 | -- |
| 2026-08-13 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +16 | -- |
| 2026-08-13 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +32 | -- |
| 2026-08-04 | David Fischer | Independent Director | Open Market Disposition | -1,662 | $102.31 |
| 2026-07-30 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | -- |
| 2026-07-30 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +34 | -- |
| 2026-07-14 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | -- |
| 2026-07-14 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +34 | -- |
| 2026-06-30 | Kenneth Escoe | Director | Other Acquisition | +1,516 | $98.97 |
| 2026-06-29 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +18 | -- |
| 2026-06-29 | Charles Magro | Independent Director | Other Derivative Acquisition | +265 | -- |
| 2026-06-29 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +36 | -- |
| 2026-06-14 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | -- |
| 2026-06-14 | Michael Leonard | Senior VP, Chief Innovation Officer & Head of Protein Fortification | Other Derivative Acquisition | +33 | -- |
| 2026-05-28 | Eric Seip | Senior VP of Global Operations & Chief Supply Chain Officer | Other Derivative Acquisition | +17 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.